CLDX R&D to Revenue

Celldex Therapeutics Inc · R&D to Revenue

CLDX logo

CLDX R&D to Revenue

Latest reported307040.91%
CLDX Quarterly R&D/Revenue (0.00% → 307040.91%)
High-resolution chart · PNG

CLDX r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Celldex Therapeutics Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
307,040.9091%
486,673.3333%
100,478.6667%
0%
7,424.1096%
7,570.3597%
3,925.1064%
1,418.4582%
1,556.8455%
19,798.7179%
736.5287%
2,276.5326%
9,795.5224%
2,771.2513%
1,419.6528%
5,300.2457%
12,718.4049%
9,802.2989%
4,394.6108%
11,148.366%
355.0575%
1,856.9343%
750.9908%
1,602.994%
5,595.339%
428.7023%
1,165.6144%
2,033.1502%
1,409.9301%
782.5263%
635.3175%
1,266.525%
776.2577%
537.7335%
678.9352%
558.4862%
652.8859%
1,681.4211%
1,310.4589%
1,126.5315%
1,851.0439%
2,106.4467%
1,335.1955%
2,403.1189%
1,216.2534%
5,169.7531%
1,829.7901%
2,378.2925%
4,070.9459%
6,507.2115%
2,871.6129%
2,083.3673%
15,556.701%
583.6785%
376.9674%
378.0597%
553.2106%
442.6223%
403.6154%
363.6902%
367.2643%
272.3768%
17.8733%
299.6262%
245.8828%
173.3908%
51.5529%
179.6774%
290.5773%
232.7643%
254.4483%
280.9871%
388.0314%
3,043.9857%
239.0962%
1,657.2141%
492.1388%
0.684%
1,272.5753%
1,302.7493%
883.1028%
117.3269%
474.5897%
424.3461%
538.4812%
415.2913%
176.4217%
531.8044%
377.1333%
113.9407%
250.1224%
124.5645%
247.9043%
394.9685%
346.485%
75.0636%
632.6073%
638.24%
688.7998%
776.4438%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.